President’s Pick and Perspective

Encapsulating decades of research, this article by Dr. Sudhir Agrawal, the 2022 OTS Lifetime Achievement Award recipient, explores the transformative potential of RNA-based therapies through the lens of over ...

Another stellar review article summarizing the field now published in Nucleic Acid Therapeutics. The review in Nucleic Acid Therapeutics by Jillian Belgrad and colleagues discusses the significant progress and future ...

True to the vision of OTS, we worked with our journal publisher, Mary Ann Liebert publishers, Inc., through our BOD Committees to compile a list of important open-access Nucleic ...

The OTS Annual Meeting 2023 in Barcelona was a showcase of excellent science and a demonstration of how far our field has advanced over the past nineteen years. Congratulations to ...

During the 2022 OTS annual meeting in Phoenix it was easy to listen to the talks announcing successful clinical trial results and assume that obviously favorable data were becoming ...

Researchers involved in developing oligonucleotide therapeutics have always been known for picking difficult problems related to difficult diseases. SOD1-ALS is a deadly neurodegenerative disease caused by a mutation in the ...